Nordisk Insulinlaboratorium

Novo Nordisk A/S

Type	Publicly traded Aktieselskab
Traded as	Nasdaq Copenhagen: NOVO B : NVO
Industry	Pharmaceuticals, health care
Founded	1923
Headquarters	Bagsværd, Denmark
Key people	Lars Fruergaard Jørgensen(President and CEO) Jesper Brandgaard (EVP, CFO) Maziar Mike Doustdar (EVP, Head of International Operations) Mads Krogsgaard Thomsen (EVP, CSO) Henrik Wulff (EVP, Head of Product Supply) Göran Ando (Board Chairman) Jeppe Christiansen (Board Vice Chairman)
Products	Ryzodeg, Victoza, NovoEight, Activella, Novolin, Levemir, NovoSeven, Norditropin, Tresiba, Xultophy, NovoRapid, Saxenda
Revenue	DKK 83.57 billion (2013)
Operating income	DKK 31.49 billion (2013)
Profit	DKK 25.18 billion (2013)
Total assets	DKK 70.34 billion (2013)
Total equity	DKK 42.57 billion (2013)
Number of employees	41,571 (2016)
Website	www.novonordisk.com

Lars Fruergaard Jørgensen(President and CEO)
Jesper Brandgaard (EVP, CFO)
Maziar Mike Doustdar (EVP, Head of International Operations)
Mads Krogsgaard Thomsen (EVP, CSO)
Henrik Wulff (EVP, Head of Product Supply)
Göran Ando (Board Chairman)

Novo Nordisk is a Danish multinational pharmaceutical company headquartered in Bagsværd, Denmark, with production facilities in eight countries, and affiliates or offices in 75 countries. Novo Nordisk is controlled by majority shareholder Novo Holdings A/S which holds approximately 25% of its shares and a supermajority (75%) of its voting shares.

Novo Nordisk manufactures and markets pharmaceutical products and services. Key products include diabetes care medications and devices. Novo Nordisk is also involved with hemostasis management, growth hormone therapy and hormone replacement therapy. The company makes several drugs under various brand names, including Levemir, NovoLog, Novolin R, NovoSeven, NovoEight and Victoza.

Novo Nordisk employs more than 40,000 people globally, and markets its products in 180 countries. The corporation was created in 1989 through a merger of two Danish companies which date back to the 1920s. The Novo Nordisk logo is the Apis bull, one of the sacred animals of ancient Egypt.

Novo Nordisk is a full member of the European Federation of Pharmaceutical Industries and Associations (EFPIA).